IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
Metastatic Malignant Neoplasm in the Bone
M.D. Anderson Cancer Centermonoclonal_antibodyPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
34 Active assets in the Metastatic Malignant Neoplasm in the Bone cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Ibandronate Kelly Fitzgerald, MD | Phase 4 | BBB |
Denosumab Kelly Fitzgerald, MD | Phase 4 | BBB |
Zoledronate Kelly Fitzgerald, MD | Phase 4 | BBB |
RADIUM RA-223 University of California, San Francisco | Phase 3 | BB |
Zometa Sun Yat-sen University | Phase 4 | BB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →